Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

European Journal of Cancer

Volumn 45, Issue 12, 2009, Pages 2197-2206

  Cho, William C S ^a   Chow, Andrew S C ^a   Au, Joseph S K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Epidermal growth factor receptor (EGFR); MicroRNA microarray; miR 145; Non smoking patient with lung adenocarcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 67650365554     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.039     Document Type: Article

References (35)

1. Thun M.J., Hannan L.M., Adams-Campbell L.L., et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts, 22 cancer registry studies. PLoS Med 5 (2008) e185
2. Toh C.K., and Lim W.T. Lung cancer in never-smokers. J Clin Pathol 60 (2007) 337-340
3. Wakelee H.A., Chang E.T., Gomez S.L., et al. Lung cancer incidence in never smokers. J Clin Oncol 25 (2007) 472-478
4. Au J.S., Cho W.C., Yip T.T., et al. Deep proteome profiling of sera from never-smoked lung cancer patients. Biomed Pharmacother 61 (2007) 570-577
5. Sun S., Schiller J.H., and Gazdar A.F. Lung cancer in never smokers - a different disease. Nat Rev Cancer 7 (2007) 778-790
6. Yen C.C., Liang S.C., Jong Y.J., et al. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. Lung Cancer 57 (2007) 292-301
7. Mountzios G., Fouret P., and Soria J.C. Mechanisms of disease: signal transduction in lung carcinogenesis - a comparison of smokers and never-smokers. Nat Clin Pract Oncol 5 (2008) 610-618
8. Cho W.C. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother 61 (2007) 515-519
9. Lagos-Quintana M., Rauhut R., Lendeckel W., and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294 (2001) 853-858
10. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
11. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6 (2007) 60
12. Au J.S., Cho W.C., Yip T.T., and Law S.C. Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest 26 (2008) 128-135
13. Miura K., Bowman E.D., Simon R., et al. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62 (2002) 3244-3250
14. Powell C.A., Spira A., Derti A., et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am J Respir Cell Mol Biol 29 (2003) 157-162
15. Heguy A., O'Connor T.P., Luettich K., et al. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 84 (2006) 318-328
16. Messersmith W.A., and Ahnen D.J. Targeting EGFR in colorectal cancer. New Engl J Med 359 (2008) 1834-1836
17. Kelly M.P., Lee S.T., Lee F.T., et al. Therapeutic efficacy of 177Lu-CHX-A"-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy. Prostate 69 (2009) 92-104
18. Toyama T., Yamashita H., Kondo N., et al. Frequently increased epidermal growth factor receptor (EGFR) copy numbers, decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. BMC Cancer 8 (2008) 309
19. Ding L., Getz G., Wheeler D.A., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455 (2008) 1069-1075
20. Morinaga R., Okamoto I., Fujita Y., et al. Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer. Cancer Sci 99 (2008) 2455-2460
21. Sonobe M., Manabe T., Wada H., and Tanaka F. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer 93 (2005) 355-363
22. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
23. Meng F., Henson R., Lang M., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130 (2006) 2113-2129
24. Tran N., McLean T., Zhang X., et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358 (2007) 12-17
25. Fulci V., Chiaretti S., Goldoni M., et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109 (2007) 4944-4951
26. Markou A., Tsaroucha E.G., Kaklamanis L., et al. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54 (2008) 1696-1704
27. Musiyenko A., Bitko V., and Barik S. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med 86 (2008) 313-322
28. Bandres E., Cubedo E., Agirre X., et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer, non-tumoral tissues. Mol Cancer 5 (2006) 29
29. Wang X., Tang S., Le S.Y., et al. Aberrant expression of oncogenic, tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3 (2008) e2557
30. Camps C., Buffa F.M., Colella S., et al. Hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14 (2008) 1340-1348
31. Giannakakis A., Sandaltzopoulos R., Greshock J., et al. MiR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7 (2008) 255-264
32. Lawrie C.H., Gal S., Dunlop H.M., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141 (2008) 672-675
33. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., and James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1 (2003) 882-891
34. Diederichs S., and Haber D.A. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res 66 (2006) 6097-6104
35. Izzotti A., Calin G.A., Arrigo P., et al. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23 (2009) 806-812